Enhancement of lymphocyte proliferation induced by interleukin-12 and anti-interleukin-10 in HIV-infected patients during highly active antiretroviral therapy
E. Stylianou et al., Enhancement of lymphocyte proliferation induced by interleukin-12 and anti-interleukin-10 in HIV-infected patients during highly active antiretroviral therapy, APMIS, 108(9), 2000, pp. 601-607
Based on the potentially important role of IL-10 and IL-12 in the pathogene
sis of HIV infection, we have examined the effect of highly active antiretr
oviral therapy (HAART) on the production of these two cytokines, and whethe
r addition of IL-12 or anti-IL-10 in vitro could improve the proliferative
response in peripheral blood mononuclear cells (PBMC) from HIV-infected pat
ients during such therapy. Our findings are: (i) After initiating HAART the
re were no significant changes in PHA- or MAC-PPD-stimulated IL-10 and IL-1
2 levels in PBMC supernatants in the patient group as a whole. (ii) However
, while a decline in IL-10 synthesis was shown in patients with high baseli
ne MAC-PPD- and PHA-stimulated IL-10 levels, IL-10 increased in patients wi
th lower baseline levels. A similar pattern was seen for MAC-PPD-stimulated
IL-12 levels. (iii) Exogenously added IL-12 and anti-IL-10 markedly and ad
ditively improved MAC-PPD-stimulated PBMC proliferation in vitro. Thus, a l
oss of cell-mediated immune response exists in HIV-infected patients also d
uring apparently successful HAART and this can be significantly improved by
addition of IL-12 and anti-IL-10, at least in vitro. These results suggest
that further exploration of both IL-10 and IL-12 as targets for immunomodu
lating therapy in HIV-infected patients in addition to HAART might be impor
tant.